Back

Prescription of sacubitril/valsartan in a real-world population

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Joao AGOSTINHO

North Lisbon University Hospital Centre, CAML, CCUL, Lisbon School of Medicine, Lisbon (Portugal)

55 More presentations in this session

Presentation thumbnail
Doctor A. Ntalianis (Athens, GR)
Abstract
Presentation thumbnail
Doctor F. Ferreira (Lisbon, PT)
Abstract
Presentation thumbnail
Ms E. O'Donoghue (Dublin, IE)
Abstract
Presentation thumbnail
Doctor V. Gomez Leiva (San Salvador, SV)
Abstract Slides
Presentation thumbnail
Doctor F. Batar (Sibiu, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril/Valsartan efficacy on functional, laboratory, echocardiographic parameters: a real-world study
29 June 2021
thumbnail
Congress Presentation
Eligibility and prescribing rates of SGLT2 inhibitors for ambulatory patients with heart failure and reduced ejection fraction in a multidisciplinary heart failure management programme
26 August 2023
thumbnail
Congress Presentation
Treatment trajectory of Sacubitril/Valsartan initiation among >50,000 older adults with heart failure with reduced ejection fraction in the United States
21 May 2023
thumbnail
Congress Presentation
Elegibility for Sacubitril/Valsartan in italian clinical practice: insights from the OPTIMA-HF registry
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources